Throat Lozenges Market Report 2025

The throat lozenges market size has grown strongly in recent years. It will grow from $5.1 billion in 2024 to $5.37 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to increased incidence of throat discomfort, consumer awareness and self-care trends, preference for natural and herbal ingredients, change in lifestyles and environmental factors, marketing and branding strategies.

The throat lozenges market size is expected to see strong growth in the next few years. It will grow to $6.9 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to continued prevalence of respiratory conditions, innovation in flavor profiles, e-commerce and online retail growth, health and wellness trends, global respiratory health awareness. Major trends in the forecast period include e-commerce growth, targeted marketing for specialty formulations, global health events impact, inclusion of soothing herbs and extracts, customization and personalization.

The anticipated growth in the throat lozenges market is driven by the increasing prevalence of respiratory diseases. Respiratory diseases encompass conditions affecting the lungs and other parts of the respiratory system. Throat lozenges play a role in treating respiratory tract infections and diseases. As of September 2022, the Forum of International Respiratory Societies (FIRS) reported that approximately 200 million people globally are afflicted with chronic obstructive pulmonary disease (COPD), resulting in around 3.2 million annual deaths. Consequently, the rising prevalence of respiratory diseases is expected to boost the throat lozenges market.

The expanding prevalence of flu illnesses is anticipated to contribute to the growth of the throat lozenges market. Flu illnesses, caused by influenza viruses, are contagious respiratory conditions affecting the nose, throat, and sometimes the lungs. Throat lozenges provide relief by stimulating saliva production, soothing dry or irritated throats associated with flu illnesses. According to the Centers for Disease Control and Prevention (CDC), in the US during the 2021-22 period, there were approximately 9.4 million flu illnesses, leading to 4.3 million flu-related medical visits. Furthermore, the same period saw around 4,900 flu-related deaths and 100,000 flu-related hospitalizations. Hence, the growing prevalence of flu illnesses is a driving factor for the throat lozenges market.

The throat lozenges market is witnessing a notable trend in the introduction of innovative product offerings. Major companies within the throat lozenges market are actively launching diverse and inventive products to maintain and enhance their market standing. For example, in July 2022, Taiho Pharmaceutical Co Ltd., a Japan-based pharmaceutical company, unveiled the PITAS throat troche series - a range of film-type lozenges designed to alleviate throat pain, swelling, and discomfort. These lozenges adhere to the roof of the mouth, ensuring discreet use and effectiveness even during conversation. The PITAS Medical Troche is specifically formulated as a designated quasi-drug for mouth and throat disinfection.

Major companies in the throat lozenges market are focusing on developing innovative products, such as herbal formulation lozenges, to improve the effectiveness of sore throat relief while meeting the rising consumer demand for natural ingredients. Herbal formulation lozenges are beneficial in the throat lozenges sector because they provide natural soothing effects, alleviating discomfort and offering a gentler alternative to synthetic components. For example, in September 2024, Cipla Health Limited, a pharmaceuticals company based in India, launched Cofsils Mulethi Lozenges for rapid relief from sore throats. These lozenges combine the soothing properties of mulethi (liquorice) with other herbal ingredients. Cofsils Mulethi Lozenges promise quick relief from sore throat discomfort within five minutes, employing a unique Triple Relief Formula that incorporates antiviral, antibacterial, and local anesthetic properties. Each lozenge contains active ingredients like 2,4-amylmetacresol and dichlorobenzyl alcohol, which work in synergy to soothe irritation and provide effective pain relief.

In September 2024, Dr. Reddy’s Laboratories, a pharmaceutical company based in India, acquired Haleon plc for an undisclosed amount. This acquisition aims to enhance Dr. Reddy’s global footprint in the nicotine replacement therapy market, broaden its over-the-counter (OTC) product portfolio with Nicotinell, and bolster its consumer healthcare offerings. The deal is designed to support sustainable growth, align with World Health Organization (WHO) guidelines, and create opportunities for future product development and revenue expansion. Haleon plc, a consumer healthcare company located in the UK, is known for producing throat lozenges under popular brands like Strepsils and Theraflu, which effectively relieve sore throats and coughs.

Major companies operating in the throat lozenges market include GlaxoSmithKline plc, SSL International plc, Thornton & Ross, Pfizer Inc., The Procter & Gamble Company, Bausch Health Companies Inc., Wrigley Company, Reckitt Benckiser Group plc, Gepach International, Bliss GVS Pharma Ltd, Sanofi S.A, Ricola AG, Honibe, Ernest Jackson & Co Ltd, Doetsch Grether AG, Mondelēz International group, Cloetta AB, Golden Throat, Fisherman's Friend, Prestige Brands Inc, HALLS, Dabur India Limited, Churub, Strepsils, Cepac, Chlorhexidine.

North America was the largest region in the global throat lozenges market in 2024. Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the throat lozenges market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the throat lozenges market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Throat lozenges are medicinal candies designed to alleviate throat discomfort. These lozenges offer temporary relief for conditions such as sore throat, throat irritation, or cough.

Throat lozenges come in various types, including hard candy lozenges, soft lozenges, and compressed lozenges. Hard candy lozenges are characterized by their amorphous or glassy state and are used as a form of medication to provide pain relief in the mouth and pharynx, particularly for sore throats. The ingredients in throat lozenges encompass menthol, mint, eucalyptus oil, peppermint oil, honey and ginger, lemon, and others. These lozenges are available through different distribution channels such as hospital pharmacies, retail pharmacies, online pharmacies, and others, offering treatment for conditions such as sore throat, cough and cold, as well as various throat ailments.

The throat lozenges market research report is one of a series of new reports that provides throat lozenges market statistics, including throat lozenges industry global market size, regional shares, competitors with a throat lozenges market share, detailed throat lozenges market segments, market trends, and opportunities, and any further data you may need to thrive in the throat lozenges industry. This throat lozenges market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The throat lozenges market consists of sales of chewable and cough drops. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.